Galena Biopharma Inc news

   Watch this stock
Showing stories 1 - 10 of about 106   

Articles published

GALE 1.58 0.00 (-0.32%)
price chart
Galena Biopharma, Inc. Stock Alert: Schubert Firm Investigates Potential ...
31, 2015 /PRNewswire/ -- On August 5, 2015, the U.S. District Court for the District of Oregon denied motions to dismiss securities class action claims against Galena Biopharma, Inc. (NASDAQ: GALE) and certain of its directors. The class actions allege ...
Company Shares of Galena Biopharma, Inc. (NASDAQ:GALE) Rally 11.94%  News Watch International
Galena Biopharma, Inc. Analyst Rating Update
Galena Biopharma, Inc. (NASDAQ:GALE) has received a short term rating of hold from research analysts at Zacks with a rank of 3. The company has been rated an average of 2.2 by 5 Wall Street Analysts.
Galena Biopharma to Present at Two Upcoming Healthcare Investment Conferences  MarketWatch
Biotech Stocks that your portfolio will love: Galena Biopharma Inc (NASDAQ ...
Investors have been flocking to biotech stocks this year, with the IBB, the ETF that tracks biotech stocks, making noteworthy gains.
Biotech Stocks that your portfolio will love: Galena Biopharma Inc (NASDAQ ...
They say good things come in threes. If so, biotech companies could be in for not just another year of outperformance, but another decade.
Active Biotech Stock News - ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), Galena ...
Galena Biopharma Inc(NASDAQ:GALE)rose 0.67% to finish last trading session at $1.50. The company, on August 24, 2015,declared that the Independent Data Monitoring Committee (IDMC) has recommended to the Company that it can reduce the cardiac ...
Weekly Investment Analysts' Ratings Changes for Galena Biopharma (GALE)
8/12/2015 - Galena Biopharma was downgraded by analysts at Zacks from a “buy” rating to a “hold” rating. According to Zacks, “Galena Biopharma, Inc. is a biopharmaceutical company that develops innovative, targeted oncology treatments that address ...
Galena Biopharma, Inc. (NASDAQ:GALE) Price Target Update  Insider Trading Report
Stocks on the Move – Galena Biopharma Inc (GALE), Palatin Technologies, Inc ...  Investor Wired
Biotech Stocks to bet on: Galena Biopharma Inc (GALE), Array Biopharma Inc ...
Galena Biopharma Inc (NASDAQ:GALE) ended at $1.61 by gaining 7.33%. The $241.08M company on August 24, 2015 announced that the Independent Data Monitoring Committee (IDMC) has recommended to the Company that it can reduce the cardiac ...
Zacks Short Term Rating on Galena Biopharma, Inc. (NASDAQ:GALE)  Insider Trading Report
Stock Update (NASDAQ:GALE): Galena Biopharma Inc Announces IDMC Recommends ...  Smarter Analyst
Why Shares of Galena Biopharma, Inc. Spiked Today
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
Galena Biopharma Inc (GALE)'s Bullish Stance Reiterated at Maxim Ahead ...  Smarter Analyst
Galena Biopharma (GALE) Stock Climbs On Abstract Publications  CNA Finance (press release)
Stock Update (NASDAQ:GALE) Galena Biopharma Inc Launches Zuplenz(R) Oral ...
Galena Biopharma Inc. (NASDAQ:GALE), a biopharmaceutical company developing and commercializing innovative, targeted oncology therapeutics that address major medical needs across the full spectrum of cancer care, today announced the product ...
Galena Biopharma Launches Zuplenz Oral Soluble Film  Benzinga
Galena Biopharma Launches Zuplenz(R) (ondansetron) Oral Soluble Film  GlobeNewswire (press release)
Short Interest Update on Galena Biopharma, Inc. (NASDAQ:GALE)
Galena Biopharma, Inc. (NASDAQ:GALE) ensharesed a rise of 4.3% or 884,316 shares in the short positions. The number escalated from 20,421,255 on July 15,2015 to 21,305,571 on July 31,2015.
Galena Biopharma (GALE) - Investment Analysts' Recent Ratings Changes  Dakota Financial News